From: Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study
Gender
n (%)
Female
20 (50)
Male
Rivaroxaban dosage
10 mg/day
12 (30.0)
15 mg/day
19 (47.5)
20 mg/day
9 (22.5)
Age
Average (standard deviation)
69 (21)
Minimum and maximum age
27–95